HFE-associated hereditary hemochromatosis: Overview of genetics and clinical implications for nurse practitioners in primary care settings

Journal of the American Association of Nurse Practitioners

Volumn 26, Issue 3, 2014, Pages 113-122

  Emanuele, Donna ^a   Tuason, Ivy ^a   Edwards, Quannetta T ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Digestive system; Genetics; Liver; Nurse practitioners; Primary care

Indexed keywords

GENETICS; HEMOCHROMATOSIS; HUMAN; MUTATION; NURSE PRACTITIONER; NURSING; PATHOLOGY; PEDIGREE; PRIMARY HEALTH CARE; PROCEDURES;

HEMOCHROMATOSIS; HUMANS; MUTATION; NURSE PRACTITIONERS; PEDIGREE; PRIMARY HEALTH CARE;

EID: 84898606598     PISSN: 23276886     EISSN: 23276924     Source Type: Journal    
DOI: 10.1002/2327-6924.12106     Document Type: Article

References (39)

1. Abolaban, H., Fares, M., Haydour, Q., Ibrahim, N., Rayess, D., Diab, M., & Al Moujahed, A. M. (2010). Erythrocytapheresis versus phlebotomy for hereditary haemochromatosis (protocol)-The Cochrane Collaboration©. Cochrane Database of Systematic Reviews, Issue 11. Art. No. CD008855. doi:10.1002/14651858.CD008855. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008855/pdf
2. Adams, P. C., & Barton, J. C. (2010). How I treat hemochromatosis. Blood, 116(3), 317-325. Retrieved from http://bloodjournal.hematologylibrary.org/content/116/3/317.full
3. Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C.E., Eckfeldt, J. H., ... Sholinsky, P. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352, 1769-1778.
4. Agency for Healthcare Quality and Research. (2011) Section 2. Recommendations for adults (continued): Guide to clinical preventive services, 2012-Screening for hemochromatosis. Rockville, MD: Author. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/section2b.html
5. Allen, M. K. (2010). Hereditary hemochromatosis: A literature review and case report. Physiotherapy Canada, 62(3), 276-284
6. American Hemochromatosis Society. (n. d.). FAQ's about hemochromatosis/iron overload. Retrieved from http://www.americanhs.org/faq.htm
7. Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011). Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Disease. Hepatology, 54(1), 328-43.
8. Barton, J. C., & Action, R. T. (2009). Hemochromatosis and Vibrio vulnificus wound infections. Journal of Clinical Gastroenterology 43(9), 890-3. doi:10.1097/MCG.0b013e31819069c1.
9. Beutler, E., Fellitti, V. J., Kozioi, J. A., Ho, N. J., & Gelbart, T. (2002). Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet, 359(9302), 211-218.
10. Brissot, P., Bardou-Jacquet, P., Troadec, M.-B., Mosser, A., Island, M.-L., Detivaud, L., ... Jouanolle, A.-M. (2010). Molecular diagnosis of genetic iron-overload disorders. Expert Review of Molecular Diagnostics, 10(6), 755-763.
11. Burke, W., Cogswell, M. E., McDonnell, S. M., & Franks, A. (2000). Public health strategies to prevent the complications of hemochromatosis. In Khoury, M.J Burke, W & Thomson, E. J (eds) Genetics and public health in the 21st century (chap. 23 p. 447). Oxford University Press. Retrieved from http://www.cdc.gov/genomics/resources/books/21stcent/chap23.htm
12. Collins, J. F., Wessling-Resnick, M., & Knutson, M. D. (2008). Hepcidin regulation of iron transport. Journal of Nutrition, 138(11), 2284-2288. doi:10.3945/jn.108.096347.
13. Duchini, A., Katz, J., Steir, H. E., Klachko, D.M., Gumaste, V. V., Heuman, D. M., Takavera F. (2013). Hemochromatosis. In Medscape [Internet]. Retrieved from http://emedicine.medscape.com/article/177216-overview
14. Edwards, Q. T., Maradiegue, A., Mcari, C., & Sitzer, L. (2006). Faculty members' perceptions of medical genetics and its integration into nurse practitioner curricula. Journal of Nursing Education, 45(3), 124-130.
15. European Association for the Study of the Liver (EASL). (2010). EASL Clinical Practice Guidelines for HFE hemochromatosis. Journal of Hepatology. doi:10.1016/j.jhep.2010.03.001. Retrieved from http://www.easl.eu/assets/application/files/03d32880931aac9_file.pdf
16. Gan, E. K., Powell, L. W., & Olynyk, J. K. (2011). Natural history and management of HFE-hemochromatosis. Seminars in Liver Disease, 31(3):293-301
17. Ganz, T. (2011). Hepcidin and iron regulation, 10 years later. Blood, 117(17), 4425-4433.
18. Genetrack Biolabs. (2013). Results of testing the HFE gene. Retrieved from http://www.hemochromatosisdna.com/dna-testing/results-of-testing-the-hfe-gene
19. Greco, K. E., Tinley, S., & Seibert, D. (2011). Essential genetic and genomic competencies for nurses with graduate degrees. Retrieved from http://nursingworld.org/MainMenuCategoriesEthicsStandards/Genetics-1/Essential-Genetic-and-Genomic-Competencies-for-Nurses-With-Graduate-Degrees.pdf
20. Joffe, S., Karani, J., Lamki, N., Coombs, B. D., Schmiedl, U. P., Krasny, R. M. & Karani, J. (2013). Hemochromatosis imaging. In Medscape (internet) Retrieved from http://emedicine.medscape.com/article/369012-overview.
21. King, C., & Barton, D. E. (2006). Best practice guidelines for the molecular genetics diagnosis of type I (HFE-related) hereditary haemochromatosis. BMC Medical Genetics, 7, 81-88.
22. Kowdley, K. V., Bennett, R. L., & Motulsky, A. G. (2012). HFE-associated hereditary hemochromatosis. In: Pagon RA, Bird TD, Dolan CR, et al. (Eds.). GeneReviews™ [Internet]. Seattle, WA: University of Washington. Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK1440/
23. Laudicina, R. J. (2001). Hereditary hemochromatosis: A case study and review. Clinical Laboratory Science, 14(3), 196-213.
24. McCarthy, G. M., McCarthy, C. J., Kenny, D., Crowe, J., & Eustace, S. (2002). Hereditary hemochromatosis: A common, often unrecognized, genetic disease. Cleveland Clinic Journal of Medicine, 69(3), 224-237.
25. Moyer, T. P., Highsmith, W. E., Smyrk, T. C., & Gross, J. B., Jr. (2011). Hereditary hemochromatosis: Laboratory evaluation. Clinica Chimica Acta, 412, 1485-1492.
26. National Heart Lung and Blood Institute. (2011). What is hemochromatosis? Retrieved from http://www.nhlbi.nih.gov/health/dci/Diseases/hemo/hemo_all.html
27. Online Mendelian Inheritance in Man, OMIM® (OMIM). (2012). Hemochromatosis. Baltimore, MD: Johns Hopkins University. OMIM number: 235200: 2012. Retrieved from: http://omim.org/entry/235200?search=hemochromatosis&highlight=haemochromatosi%20hemochromatosi
28. Pagon, R. A., Bird, T. D., Dolan, C. R., et al. (Eds.). (1993-2013). GeneReviews™ [Internet]. Illustrated Glossary. Seattle, WA: University of Washington. Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK5191/
29. Pagon, R. A., Adam, M. P., Bird, T. D., et al., editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014. GeneReviews Illustrated Glossary Instructions. 2013 Jun 3. Available from: http://www.ncbi.nlm.nih.gov/books/NBK5190/
30. Pedersen, P., & Milman, N. (2009). Genetic screening for HFE hemochromatosis in 6, 020 Danish men: Penetrance of C282Y, H63D and S65C variants. Annals of Hematology, 88(8), 775-784.
31. Pietrangelo, A. (2010). Hereditary hemochromatosis: Pathogenesis, diagnosis and treatment. Gastroenterology, 139(2), 393-408, 408.e1-2. Retrieved from http://www.gastrojournal.org/article/S0016-5085%2810%2900872-3/fulltext?refuid=S0016-5085%2811%2901170-X&refissn=0016-5085
32. Poullin, P. and Lefevre, P. A. (2011). Effectiveness of therapeutic erythrocytapheresis to achieve iron depletion in hereditary type 1 hemochromatosis: Report of 30 cases. Transfusion in Clinical Biology, 19(5-6), 553-558.
33. Rombout-Sestrienkova, E., Nieman, F. H., Essers, B. A., van Noord, P. A., Janssen, M. C., van Deursen, C. T., ... Koek, G. H. (2012). Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: Results from a randomized trial. Transfusion, 52(3), 470-477.
34. Rossi, E. (2005). Hepcidin-The iron regulatory hormone. Clinical Biochemical Review, 26(3): 47-49. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240030/
35. Santos, P. C. J. L, Krieger, J. E., & Pereira, A. C. (2012). Molecular diagnostic and pathogenesis of hereditary hemochromatosis. International Journal of Molecular Sciences, 13, 1497-1511. doi:10.3390/ijms13021497.
36. Schmitt, B., Golub, R. M., & Green, R. (2005). Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians. Annals of Internal Medicine, 143(7), 522-536.
37. Toland, A. E. (2011). Hereditary hemochromatosis-Genes can affect hemochromatosis severity. Retrieved from http://www.genetichealth.com/HCROM_Possible_Mutation_Combinations_in_Hemochromatosis.shtml
38. Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L., & Smith, P. R. (2006). Screening for hereditary hemochromatosis: A systematic review for the U. S. preventative services task force. Annals of Internal Medicine, 145, 209-223.
39. Yen, A. W., Fancher, T. L., & Bowlus, C. L. (2006). Revisiting hereditary hemochromatosis: Current concepts and progress. American Journal of Medicine, 119, 391-399.